MCID: NRR001
MIFTS: 42

Neuroretinitis

Categories: Eye diseases, Neuronal diseases

Aliases & Classifications for Neuroretinitis

MalaCards integrated aliases for Neuroretinitis:

Name: Neuroretinitis 12 14 69
Juxtapapillary Focal Retinitis and Retinochoroiditis 12 69
Retinitis 42 69
Focal Retinitis and Retinochoroiditis, Juxtapapillary 12
Papilloretinitis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10176
ICD10 33 H30.9
MeSH 42 D012173
SNOMED-CT 64 410471004
UMLS 69 C0154874

Summaries for Neuroretinitis

MalaCards based summary : Neuroretinitis, also known as juxtapapillary focal retinitis and retinochoroiditis, is related to uveitis and irvan syndrome. An important gene associated with Neuroretinitis is CD40LG (CD40 Ligand). The drugs 4-Aminopyridine and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include heart, breast and brain, and related phenotypes are homeostasis/metabolism and hematopoietic system

Wikipedia : 72 Cat-scratch disease (CSD) is a common and usually benign infectious disease caused by the bacterium... more...

Related Diseases for Neuroretinitis

Diseases related to Neuroretinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 137)
id Related Disease Score Top Affiliating Genes
1 uveitis 30.4 CD40LG LYZ
2 irvan syndrome 11.8
3 leukodystrophy 10.9 CD40LG EXTL3
4 diphyllobothriasis 10.8 CD40LG EXTL3
5 malignant hypertensive renal disease 10.8 CD40LG EXTL3
6 fallopian tube cystadenofibroma 10.8 CD40LG EXTL3
7 vascular skin disease 10.8 CD40LG EXTL3
8 alopecia areata 10.8 CD40LG EXTL3
9 heart septal defect 10.8 CD40LG RNASE3
10 cerebral neuroblastoma 10.8 CD40LG EXTL3
11 acute ethmoiditis 10.8 ACE CD40LG
12 mitochondrial encephalomyopathy 10.8 CD40LG EXTL3
13 choroidal sclerosis 10.8 CD40LG RNASE3
14 chordoid glioma 10.8 EXTL3 FLNA
15 malignant eyelid melanoma 10.8 CD40LG EXTL3
16 basilar artery occlusion 10.8 CD40LG EXTL3
17 somatoform disorder 10.7 CD40LG RNASE3
18 vulvovaginal candidiasis 10.7 CD40LG FLNA
19 retinitis pigmentosa 70 10.7 ACE VEGFA
20 pseudovascular skin squamous cell carcinoma 10.7 CD40LG TNFRSF10A
21 epithelial predominant pulmonary blastoma 10.7 ACE RNASE3
22 achilles bursitis 10.7 CD40LG RNASE3
23 temporal arteritis 10.6 CD40LG MOG
24 hypercalcemic sarcoidosis 10.6 ACE LYZ
25 kidney carcinoma in situ 10.6 CD40LG TNFRSF10A
26 spoan syndrome 10.6 CD40LG IFNB1
27 immune-complex glomerulonephritis 10.6 CD40LG LYZ
28 heart disease 10.6 ACE FLNA
29 bullous retinoschisis 10.6 EXTL3 FLNA
30 bejel 10.6 AQP4 CA2
31 acute chest syndrome 10.5 ACE CD40LG RNASE3
32 lens disease 10.5 AQP4 VEGFA
33 vulvar sarcoma 10.5 CD40LG TNFRSF10A
34 central nervous system leiomyosarcoma 10.5 CD40LG TNFRSF10A
35 cogan-reese syndrome 10.5 AQP4 IFNB1
36 cellular schwannoma 10.4 AQP4 CD40LG MOG
37 membranoproliferative glomerulonephritis 10.4 ACE CD40LG LYZ
38 ureteral lymphoma 10.4 CD40LG RNASE3 TNFRSF10A
39 acitretin/etretinate embryopathy 10.4 RCVRN VEGFA
40 central nervous system vasculitis 10.4 CA2 LYZ VEGFA
41 calcinosis 10.4 ACE CD40LG LYZ
42 renal adenoma 10.4 LYZ VEGFA
43 postinflammatory pulmonary fibrosis 10.4 CD40LG LYZ
44 lymphoma 10.4 ACE CD40LG TNFRSF10A
45 hypolipoproteinemia 10.3 ACE CD40LG IFNB1
46 retinitis 10.3
47 ostertagiasis 10.3 ACE CD40LG IFNB1
48 glycogen storage disease viii 10.3 CD40LG LYZ
49 placental insufficiency 10.3 CD40LG MLN
50 vasculitis 10.3

Graphical network of the top 20 diseases related to Neuroretinitis:



Diseases related to Neuroretinitis

Symptoms & Phenotypes for Neuroretinitis

MGI Mouse Phenotypes related to Neuroretinitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.06 CD40LG EXTL3 FLNA IFNB1 LYZ TNFRSF10A
2 hematopoietic system MP:0005397 10.02 ACE AQP4 CD40LG FLNA IFNB1 LYZ
3 endocrine/exocrine gland MP:0005379 10.01 ACE AQP4 CA2 CD40LG EXTL3 LYZ
4 immune system MP:0005387 9.96 ACE AQP4 CA2 CD40LG FLNA IFNB1
5 nervous system MP:0003631 9.81 DPYSL5 FLNA IFNB1 LYZ MOG VEGFA
6 no phenotypic analysis MP:0003012 9.43 AQP4 IFNB1 LYZ TNFRSF10A UBL4A VEGFA
7 renal/urinary system MP:0005367 9.1 ACE AQP4 CA2 CD40LG LYZ VEGFA

Drugs & Therapeutics for Neuroretinitis

Drugs for Neuroretinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 402)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
4-Aminopyridine Approved Phase 4 504-24-5 1727
2
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
3
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
4
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
5
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
6
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
7
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
8
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Early Phase 1 437-38-7 3345
10
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
11
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
12
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
13
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
14
Lymecycline Approved Phase 4 992-21-2 5280963
15
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
16
Aluminum hydroxide Approved Phase 4,Phase 2 21645-51-2
17
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
18
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
19
Imipramine Approved Phase 4 50-49-7 3696
20
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
21
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
22
Clozapine Approved Phase 4 5786-21-0 2818
23
Insulin Detemir Approved Phase 4 169148-63-4 5311023
24
Zinc Approved Phase 4 7440-66-6 32051 23994
25
Capsaicin Approved Phase 4 404-86-4 1548943
26
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
27
Everolimus Approved Phase 4,Phase 2 159351-69-6 6442177
28
Sirolimus Approved, Investigational Phase 4,Phase 2 53123-88-9 5284616 6436030 46835353
29
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
30
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
31
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
32
Leuprolide Approved, Investigational Phase 4,Phase 1 53714-56-0 3911 657181
33
Pantoprazole Approved Phase 4 102625-70-7 4679
34
Tamoxifen Approved Phase 4 10540-29-1 2733526
35
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 14219 4091
36
Ganirelix Approved Phase 4 123246-29-7, 124904-93-4 25081094
37
Menotropins Approved Phase 4 61489-71-2, 9002-68-0 5360545
38
Methylnaltrexone Approved Phase 4 83387-25-1, 916055-93-1 6603824
39
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
40
Ticagrelor Approved Phase 4 274693-27-5 9871419
41
Furosemide Approved, Vet_approved Phase 4,Phase 1 54-31-9 3440
42
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
43
Piperacillin Approved Phase 4 66258-76-2 43672
44
Tazobactam Approved Phase 4 89786-04-9 123630
45
Paclitaxel Approved, Vet_approved Phase 4 33069-62-4 36314
46
Caffeine Approved, Nutraceutical Phase 4 58-08-2 2519
47
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
48
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 3 67-97-0 6221 10883523 5280795
49
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-14-6 5280793
50
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 1406-16-2

Interventional clinical trials:

(show top 50) (show all 375)

id Name Status NCT ID Phase Drugs
1 Resistance Training and Amino Pyridine in Multiple Sclerosis Unknown status NCT02143167 Phase 4 SR-fampridine;Placebo
2 Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Unknown status NCT02484105 Phase 4
3 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4 Gabapentin;S-ketamine;Lidocaine;Droperidol
4 Optimal Multimodal Analgesia in Abdominal Hysterectomy Unknown status NCT00209872 Phase 4 Gabapentin;Lidocaine;S-ketamine
5 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
6 SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents Unknown status NCT00714545 Phase 4
7 Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety. Unknown status NCT02226328 Phase 4 Propofol sedation;Midazolam and Fentanyl sedation
8 Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair Unknown status NCT01326039 Phase 4 bupivacaine;saline
9 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
10 Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial Unknown status NCT02477371 Phase 4
11 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
12 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
13 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4 Imipramine;Pregabalin;Imipramine, pregabalin;Placebo
14 Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair Unknown status NCT00960011 Phase 4
15 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Completed NCT02625103 Phase 4 Clozapine
16 Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Completed NCT01308554 Phase 4 Placebo: sterile normal saline;Marcaine
17 Santyl vs. Sharp Debridement of Diabetic Foot Wounds Completed NCT01056198 Phase 4 Santyl
18 Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients Completed NCT00742976 Phase 4 Insulin Detemir; Insulin Insulatard;Insulin Detemir, Insulin Insulatard
19 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Completed NCT01656148 Phase 4 Fampridine-SR
20 Effects of NSK-SD (Nattokinase) on Blood Pressure Completed NCT02886507 Phase 4
21 The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods Completed NCT01048515 Phase 4 Caffeine
22 Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy Completed NCT01934088 Phase 4 Propofol;Midazolam;Fentanyl
23 Bilateral Dual TAP Block: Description of a Novel Four-point Approach Completed NCT01040234 Phase 4
24 Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls Completed NCT00115102 Phase 4 fentanyl;S-ketamine
25 The Effect of Calcium and Vitamin D in Patients With Heart Failure Completed NCT00497900 Phase 4 Vitamin D
26 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4 Hormone replacement therapy
27 Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome Completed NCT00134745 Phase 4 estradiol
28 The SORT OUT IX STEMI OCT Trial Recruiting NCT02915107 Phase 4
29 Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) Recruiting NCT02824224 Phase 4 Tamoxifen;Placebo (for Tamoxifen)
30 Corticosteroid Reduction in COPD Recruiting NCT02857842 Phase 4 Prednisolone
31 Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Recruiting NCT02797340 Phase 4 Metformin
32 Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation Recruiting NCT02069808 Phase 4 Follistim;Ganirelix;Menotropins;Leuprolide
33 Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients Recruiting NCT02942550 Phase 4 Methylnaltrexone bromide (Relistor®).;Sodium Chloride 9mg/mL
34 Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD Recruiting NCT02567214 Phase 4 Ultibro®;Spiriva®
35 Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis Recruiting NCT02831608 Phase 4
36 Pan European Collaboration on Antipsychotic Naïve Schizophrenia II Recruiting NCT02339844 Phase 4 Aripiprazole
37 Stress Ulcer Prophylaxis in the Intensive Care Unit Recruiting NCT02467621 Phase 4 Pantoprazole
38 BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Active, not recruiting NCT02623140 Phase 4
39 Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease Not yet recruiting NCT03262142 Phase 4 Piperacillin/tazobactam;Ciprofloxacin
40 The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting Not yet recruiting NCT01534221 Phase 4
41 The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study Terminated NCT01899235 Phase 4
42 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
43 Morphine, Dyspnea, Exercise and COPD Unknown status NCT01718496 Phase 3 Morphine;Placebo
44 Trial for Single Port Versus Conventional Laparoscopic Colectomy Unknown status NCT01101672 Phase 2, Phase 3
45 Lung Protective Ventilation During Robotic Assisted Prostatectomy Completed NCT02551341 Phase 3
46 Nucleoplasty for Contained Herniated Lumbar Discs Completed NCT00124774 Phase 3
47 Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial Completed NCT01304927 Phase 2, Phase 3 Cholecalciferol and calcium
48 Determining Lipid Content in Stool After Alpha-cyclodextrin Completed NCT03002168 Phase 2, Phase 3
49 The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET Completed NCT00747968 Phase 2, Phase 3 Byetta, Exenatide
50 Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis Completed NCT00864383 Phase 3 Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin

Search NIH Clinical Center for Neuroretinitis

Cochrane evidence based reviews: retinitis

Genetic Tests for Neuroretinitis

Anatomical Context for Neuroretinitis

MalaCards organs/tissues related to Neuroretinitis:

39
Heart, Breast, Brain, Spinal Cord, Testes, Liver, Lung

Publications for Neuroretinitis

Articles related to Neuroretinitis:

(show top 50) (show all 295)
id Title Authors Year
1
Unilateral neuroretinitis. ( 28416231 )
2017
2
Full-thickness macular hole: a rare complication of Borrelia burgdorferi neuroretinitis. ( 28473358 )
2017
3
Neuroretinitis as presenting and the only presentation of Lyme disease: Diagnosis and management. ( 28440258 )
2017
4
A case of suspected symptomatic Zika Neuroretinitis. ( 28736717 )
2017
5
Diffuse Unilateral Subacute Neuroretinitis Caused by Ancylostoma Hookworm. ( 28098549 )
2017
6
Neuroretinal evaluation using optical coherence tomography in patients affected by pituitary tumors. ( 28447589 )
2017
7
BARTONELLA HENSELAE NEURORETINITIS ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION, CHOROIDAL ISCHEMIA, AND ISCHEMIC OPTIC NEUROPATHY. ( 28700390 )
2017
8
Optical Coherence Tomography in Neuroretinitis: Epipapillary Infiltrates and Retinal Folds. ( 28418948 )
2017
9
Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. ( 27195096 )
2016
10
Bilateral neovascular glaucoma in idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 27085273 )
2016
11
Toxoplasmosis Neuroretinitis: A Case Report. ( 27340559 )
2016
12
Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient. ( 27525478 )
2016
13
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma. ( 27165193 )
2016
14
Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in BehAset's Disease. ( 27065852 )
2016
15
Fluorescein Photodiagnosis of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome: A Case Report and Long-Term Outcome of Photocoagulation Therapy. ( 27491854 )
2016
16
Diffuse Unilateral Subacute Neuroretinitis From Raccoon Exposure Resistant to Laser Photocoagulation. ( 27434904 )
2016
17
Choroidal neovascularization complicating optic disc drusen, mistaken for Bartonella neuroretinitis. ( 27730317 )
2016
18
Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient presenting with idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 26922651 )
2016
19
BARTONELLA QUINTANA-ASSOCIATED NEURORETINITIS: LONGITUDINAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHIC FINDINGS. ( 27258542 )
2016
20
An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292952 )
2015
21
Teaching NeuroImages: Cat-scratch optic neuropathy without neuroretinitis. ( 26078406 )
2015
22
Full-thickness macular hole in Bartonella henselae neuroretinitis in an 11-year-old girl. ( 25709274 )
2015
23
Atypical neuroretinitis in secondary chickenpox. ( 25950465 )
2015
24
Neuroretinitis in ocular bartonellosis. ( 25453244 )
2015
25
Diffuse unilateral subacute neuroretinitis in a healthy Korean male: the first case report in Korea. ( 25729261 )
2015
26
An Atypical Presentation of Bartonella Neuroretinitis. ( 26447400 )
2015
27
GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. ( 25837926 )
2015
28
The natural history of idiopathic neuroretinitis. ( 26116629 )
2015
29
Final Diagnosis in Patients Referred with a Diagnosis of Neuroretinitis. ( 27928367 )
2015
30
Optical Coherence Tomography Features in Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis Syndrome. ( 26425325 )
2015
31
A rare case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome. ( 26265851 )
2015
32
Re: An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292953 )
2015
33
Clinical experience in treatment of diffuse unilateral subretinal neuroretinitis. ( 26491239 )
2015
34
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome. ( 26441263 )
2015
35
Systemic Lupus Erythematosus Presenting as Neuroretinitis. ( 27608700 )
2015
36
Bilateral stellate neuroretinitis revealing a pheochromocytoma. ( 25995810 )
2015
37
Neuroretinitis with dual infections. ( 26527902 )
2015
38
Lyme disease associated neuroretinitis - Case report. ( 26689876 )
2015
39
Dynamics of intraretinal fluid accumulation evidenced by SD-OCT in a case of cat scratch neuroretinitis. ( 24625384 )
2014
40
Neuroretinitis secondary to Bartonella henselae in the emergent setting. ( 25497596 )
2014
41
Unilateral neuroretinitis secondary to Bartonella henselae infection. ( 24106074 )
2014
42
Evaluation of patients with diffuse unilateral subacute neuroretinitis by spectral domain optical coherence tomography with enhanced depth imaging. ( 24940045 )
2014
43
Phaeochromocytoma revealed by a stellate neuroretinitis. ( 25182462 )
2014
44
Subretinal Thelazia-induced diffuse unilateral subacute neuroretinitis. ( 25010173 )
2014
45
Subacute idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) in a child and review of paediatric cases of IRVAN revealing preserved capillary perfusion as a more common feature. ( 25233821 )
2014
46
Bilateral neuroretinitis and retinal hemorrhages in an immunocompetent patient. ( 25320946 )
2014
47
Should patients with bartonella neuroretinitis receive treatment? ( 25405664 )
2014
48
Multimodal Imaging Assisting the Early Diagnosis of Cat-Scratch Neuroretinitis. ( 25412327 )
2014
49
Neuroretinitis secondary to Bartonella henselae in the emergent setting. ( 25586979 )
2014
50
Neuroretinitis in ocular bartonellosis: a case series. ( 25120352 )
2014

Variations for Neuroretinitis

Expression for Neuroretinitis

Search GEO for disease gene expression data for Neuroretinitis.

Pathways for Neuroretinitis

GO Terms for Neuroretinitis

Cellular components related to Neuroretinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 ACE CA2 CD40LG IFNB1 LYZ RNASE3
2 extracellular region GO:0005576 9.23 ACE CD40LG FLNA IFNB1 LYZ MLN

Biological processes related to Neuroretinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 kidney development GO:0001822 9.13 ACE CA2 VEGFA
2 positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086 8.62 ACE VEGFA

Sources for Neuroretinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....